-
新型冠状病毒(SARS-CoV-2)感染在武汉爆发后,WHO将这一病毒导致的疾病命名为COVID-19(coronavirus disease in 2019)。近期,在已发表的COVID-19研究病例中,除呼吸系统疾病外,还表现出各种程度的肝损伤临床特征[1-2]。2020年1月30日发表的文章指出[3],在99例COVID-19患者中,有43例患者出现了不同程度的肝功能异常。目前,对COVID-19引起患者肝功能异常的原因尚不清楚。本文从COVID-19患者肝功能异常为切入点,通过查阅相关文献报道,试图分析造成肝损伤的因素及机制,对已出现肝功能异常的COVID-19患者,如何用药及开展相应的药学监护提供参考。
Causes of liver injury in patients with COVID-19 and treatment with hepatoprotective drugs
-
摘要: 新型冠状病毒(SARS-CoV-2)感染引起的新型冠状病毒肺炎(COVID-19)患者临床表现出不同程度的肝损伤。一系列研究表明细胞因子风暴、SARS-CoV-2病毒所致的胆管细胞损伤以及药物性肝毒性可以诱导继发性肝损伤,对不同因素所致的肝损伤的机制以及保肝药物治疗进行综述,以期为后续深入揭示该方面的研究提供参考支持。Abstract: COVID-19 patients infected with SARS-CoV-2 showed different degrees of liver injury. A series of studies have shown that cytokine storm, bile duct cell injury caused by SARS-CoV-2 and drug-induced hepatotoxicity can induce secondary liver injury. This article will review the mechanism of liver injury caused by different factors and the treatment of hepatoprotective drugs, in order to provide reference support for further research in this field.
-
Key words:
- SARS-CoV-2 /
- COVID-19 /
- liver injury /
- inflammation /
- cytokine storm
-
[1] PAN F, YE T H, SUN P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia[J]. Radiology,2020,295(3):200370. [2] DU Z W, WANG L, CAUCHEMEZ S, et al. Risk for transportation of 2019 Novel Coronavirus Disease from Wuhan to other cities in China[J]. Emerg Infect Dis,2020,26(5):1049-1052. doi: 10.3201/eid2605.200146 [3] CHEN N S, ZHOU M, DONG X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet,2020,395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7 [4] HUANG C L, WANG Y M, LI X W, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet,2020,395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5 [5] ICHIYAMA T, ISUMI H, OZAWA H, et al. Cerebrospinal fluid and serum levels of cytokines and soluble tumor necrosis factor receptor in influenza virus-associated encephalopathy[J]. Scand J Infect Dis,2003,35(1):59-61. doi: 10.1080/0036554021000026986 [6] 刘必成, 高月明. “细胞因子风暴综合征”如何识别和处理[N]. 健康报, 2020-02-20(008). [7] JENNIFER R T, MARCUS J K, CAMERON P S, et al. Into the eye of the cytokine storm[J]. Microbiol Mol Biol Rev,2012,76(1):16. doi: 10.1128/MMBR.05015-11 [8] CHOUSTERMAN B G, SWIRSKI F K, WEBER G F. Cytokine storm and Sepsis disease pathogenesis[J]. Semin Immunopathol,2017,39(5):517-528. doi: 10.1007/s00281-017-0639-8 [9] XU X W, WU X X, JIANG X G, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series[J]. BMJ,2020,368:m606. [10] 张竞文, 胡欣, 金鹏飞. 新型冠状病毒引起的细胞因子风暴及其药物治疗[J]. 中国药学杂志, 2020, 55(5):333-336. [11] 任越, 姚美村, 霍晓乾, 等. 抗新型冠状病毒方剂基于花生四烯酸代谢通路防治“细胞因子风暴”的研究[J]. 中国中药杂志, 2020, 45(6):1225-1231. [12] 何黎黎, 龚普阳, 封玥, 等. 中药在抗新型冠状病毒肺炎(COVID-19)引起的细胞因子风暴中的应用分析[J/OL]. 中草药, 2020, [2020-03-03]. http://kns.cnki.net/kcms/detail/12.1108.R.20200302.0944.004.html. [13] ZHANG Y L, JIANG C Y. Cytokine storms: the dominant hand in acute respiratory distress syndrome[J]. Life Sci(生命科学),2015,27(5):554-557. [14] SHINYA K, GAO Y W, CILLONIZ C, et al. Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque[J]. J Virol,2012,86(11):6055-6066. doi: 10.1128/JVI.00365-12 [15] CHAI X, HU L, ZHANG Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection[J]. bioRxiv, (2020-02-15)[2020-01-13]. http://www.instrument.com.cn/download/shtml/932534.shtml. [16] CHALASANI N, BONKOVSKY H L, FONTANA R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study[J]. Gastroenterology,2015,148(7):1340-1352. doi: 10.1053/j.gastro.2015.03.006 [17] 宣自学, 张国兵, 叶晓兰, 等. 新型冠状病毒肺炎患者肝损的原因分析[J]. 中国药理学通报, 2020, 36(4):591-592. doi: 10.3969/j.issn.1001-1978.2020.04.026 [18] 陈丹龙, 杨芳, 罗志英, 等. 全球抗新型冠状病毒药物研发现状和瓶颈[J]. 中国药理学通报, 2020, 36(4):459-469. doi: 10.3969/j.issn.1001-1978.2020.04.003 [19] LAN N T N, THU N T N, BARRAIL-TRAN A, et al. Randomised pharmacokinetic trial of rifabutin with lopinavir/ritonavir-antiretroviral therapy in patients with HIV-associated tuberculosis in Vietnam[J]. PLoS One,2014,9(1):e84866. doi: 10.1371/journal.pone.0084866 [20] 杨瑾, 莫国栋, 卢志军, 等. 我院107例干扰素注射液不良反应特点分析[J]. 今日药学, 2017, 27(3):199-201. doi: 10.12048/j.issn.1674-229X.2017.03.016 [21] DYSON J K, HUTCHINSON J, HARRISON L, et al. Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use[J]. J Hepatol,2016,64(1):234-238. doi: 10.1016/j.jhep.2015.07.041 [22] 聂青和. 糖皮质激素在肝衰竭治疗中的地位[J]. 中华肝脏病杂志, 2012, 20(6):414-415. [23] 聂青和. 肝衰竭综合治疗进展[J]. 实用肝脏病杂志, 2013, 16(1):17-19. [24] COTTIN J, PIERRE S, PIZZOGLIO V, et al. Methylprednisolone-related liver injury: a descriptive study using the French pharmacovigilance database[J]. Clin Res Hepatol Gastroenterol,2020-pii:S2210-7401(19)30270-0. [25] GALVAÑ V G, OLTRA M R, RUEDA D, et al. Severe acute hepatitis related to hydroxychloroquine in a woman with mixed connective tissue disease[J]. Clin Rheumatol,2007,26(6):971-972. doi: 10.1007/s10067-006-0218-1 [26] PATON N I, LEE L, XU Y, et al. Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial[J]. Lancet Infect Dis,2011,11(9):677-683. doi: 10.1016/S1473-3099(11)70065-2 [27] 孙蓉, 黄伟, 李素君, 等. 关于“柴胡劫肝阴”的源流发展与初步实验研究[J]. 中国药物警戒, 2009, 6(10):577-580. doi: 10.3969/j.issn.1672-8629.2009.10.001 [28] 孙蓉, 杨倩. 柴胡挥发油对大鼠肝能量代谢的影响[J]. 中国药理学与毒学杂志, 2011, 25(3):310-313. [29] 孙蓉, 吕丽莉, 王丽, 等. 柴胡致大鼠肝毒性氧化损伤机制研究[J]. 中药药理与临床, 2009, 25(1):49-51. [30] 张丽美, 鲍志烨, 黄幼异, 等. 半夏水提组分对小鼠肝毒性“量-时-毒”关系研究[J]. 中国药物警戒, 2011, 8(1):11-15. doi: 10.3969/j.issn.1672-8629.2011.01.003 [31] 黄伟, 张作平, 黄幼异, 等. 提取工艺对半夏急性毒性与相关物质基础含量的影响研究[J]. 中国药物警戒, 2010, 7(11):656-660. doi: 10.3969/j.issn.1672-8629.2010.11.006 [32] GEORGIOU M, SIANIDOU L, HATZIS T, et al. Hepatotoxicity due to Atractylis gummifera-L[J]. J Toxicol Clin Toxicol,1988,26(7):487-493. doi: 10.3109/15563658809038564 [33] 中华医学感染病学分会. 肝脏炎症及其防治专家共识[J]. 中国实用内科杂志, 2014, 7(1):4-12. [34] 褚扬, 周王谊, 吴江, 等. 新型冠状病毒肺炎治疗中应关注肝损伤及防治中药概述[J/OL]. 世界中医药. http://kns.cnki.net/kcms/detail/11.5529.R.20200221.0904.006.html. [35] 缪晓辉. 抗结核化疗诱导药物性肝损伤的护肝治疗[J]. 中华结核和呼吸杂志, 2013, 36:729-731. doi: 10.3760/cma.j.issn.1001-0939.2013.10.006 [36] WANG C Y, KAO T C, LO W H, et al. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate lipopolysaccharide-induced inflammatory response by suppression of NF-κB through PI3K p110δ and p110γ inhibitions[J]. J Agric Food Chem,2011,59(14):7726-7733. doi: 10.1021/jf2013265 [37] SCHROFELBAUER B, RAFFETSEDER J, HAUNER M, et al. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signaling[J]. Biochem J,2009,421(3):473-482. doi: 10.1042/BJ20082416 [38] CHEN H S, DU Q H. Potential natural compounds for preventing SARS-CoV-2 (2019-nCoV) infection[EB/OL]. 2020. DOI: 10.20944/preprints202001.0358.v3
计量
- 文章访问数: 6067
- HTML全文浏览量: 3380
- PDF下载量: 52
- 被引次数: 0